Position in OMER
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,149,338
+$5,241,898 QoQ
Shares Held
751,771
+316.2% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 172 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. OMER ranks #62 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in OMER
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,149,338 | 751,771 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,907,440 | 180,629 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,659,153 | 154,782 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $500,506 | 122,075 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $350,064 | 116,688 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $715,500 | 87,044 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $319,596 | 32,348 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $136,570 | 34,401 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $152,135 | 37,472 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $126,507 | 36,669 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $138,614 | 42,390 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $194,311 | 66,545 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $179,350 | 32,969 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $27,422 | 12,134 | Shares | Defined | 2023-02-13 | |
| 2022-03-31 | $161,151 | 26,814 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $172,934 | 26,895 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $399,991 | 29,006 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $362,511 | 24,428 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $269,598 | 15,146 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $174,909 | 12,240 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||